Cite
Plasma androgen receptor (pAR) status and activity of taxanes in metastatic castration resistant prostate cancer (mCRPC)
MLA
Elena Castro, et al. “Plasma Androgen Receptor (PAR) Status and Activity of Taxanes in Metastatic Castration Resistant Prostate Cancer (MCRPC).” Journal of Clinical Oncology, vol. 36, May 2018, p. 5074. EBSCOhost, widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........e319b41585d26ea47347804de8006197&authtype=sso&custid=ns315887.
APA
Elena Castro, Samanta Salvi, Begoña Mellado, Cristian Lolli, Giuseppe Schepisi, Anna Wingate, David Olmos, Giorgia Gurioli, Ugo De Giorgi, Daniel Wetterskog, Nuria Romero-Laorden, Emanuela Scarpi, Mercedes Marin, Anuradha Jayaram, Umberto Basso, Gerhardt Attard, Ana Medina, Enrique Gonzalez-Billalabeitia, Vincenza Conteduca, & Giuseppe Fornarini. (2018). Plasma androgen receptor (pAR) status and activity of taxanes in metastatic castration resistant prostate cancer (mCRPC). Journal of Clinical Oncology, 36, 5074.
Chicago
Elena Castro, Samanta Salvi, Begoña Mellado, Cristian Lolli, Giuseppe Schepisi, Anna Wingate, David Olmos, et al. 2018. “Plasma Androgen Receptor (PAR) Status and Activity of Taxanes in Metastatic Castration Resistant Prostate Cancer (MCRPC).” Journal of Clinical Oncology 36 (May): 5074. http://widgets.ebscohost.com/prod/customlink/proxify/proxify.php?count=1&encode=0&proxy=&find_1=&replace_1=&target=https://search.ebscohost.com/login.aspx?direct=true&site=eds-live&scope=site&db=edsair&AN=edsair.doi...........e319b41585d26ea47347804de8006197&authtype=sso&custid=ns315887.